Fig. 2From: Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood–brain barrier modelParticle size distribution of A Afa/LPN, B Afa/LPN-FD7, and C Afa/LPN-CCD and transmission electron microscopic images of D Afa/LPN, E Afa/LPN-FD7, and F Afa/LPN-CCDBack to article page